1. Home
  2. TECX vs GEMI Comparison

TECX vs GEMI Comparison

Compare TECX & GEMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$29.27

Market Cap

554.1M

Sector

N/A

ML Signal

HOLD

Logo Gemini Space Station Inc.

GEMI

Gemini Space Station Inc.

N/A

Current Price

$4.74

Market Cap

536.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
GEMI
Founded
2019
2014
Country
United States
United States
Employees
60
650
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
554.1M
536.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
GEMI
Price
$29.27
$4.74
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$75.20
$8.31
AVG Volume (30 Days)
189.7K
1.7M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$35.05
Revenue Next Year
N/A
$39.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$3.91
52 Week High
$35.99
$34.67

Technical Indicators

Market Signals
Indicator
TECX
GEMI
Relative Strength Index (RSI) 50.66 47.57
Support Level $28.31 $3.91
Resistance Level $31.88 $5.24
Average True Range (ATR) 1.53 0.30
MACD -0.17 0.09
Stochastic Oscillator 48.05 56.59

Price Performance

Historical Comparison
TECX
GEMI

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About GEMI Gemini Space Station Inc.

Gemini Space Station Inc is engaged on unlocking the next era of financial, creative, and personal freedom. It envisions a future where crypto will redesign the global financial system, the internet, and money in a way that provides greater choice, independence, and opportunity for all. As a trusted bridge between the traditional financial system and the emerging crypto economy, It is providing access for individuals and institutions to a decentralized future that is more open, fair, and secure. Its core exchange product has expanded over time to become a comprehensive platform for its users to engage with the crypto economy, including a derivatives exchange, staking services, an over-the-counter (OTC) trading desk, institutional-grade custody, and others.

Share on Social Networks: